How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals

Abstract

Innate immune detection of pathogens relies on specific classes of microbial sensors called pattern-recognition molecules (PRM). In mammals, such PRM include Toll-like receptors (TLRs) and the intracellular proteins NOD1 and NOD2, which belong to the family of Nod-like receptors (NLRs). Over the last decade as these molecules were discovered, a function in innate immunity has been assigned for the majority of them and, for most, the microbial motifs that these molecules detect were identified. One of the next challenges in innate immunity is to establish a better understanding of the complex interplay between signaling pathways induced simultaneously by distinct PRMs and how this affects tailoring first-line responses and the induction of adaptive immunity to a given pathogen.

Keywords

Toll-like receptors Nod-like receptors innate immunity

References

Fearon DT , Locksley RM The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50—53.

Girardin SE , Philpott DJ , Lemaitre B. Sensing microbes by diverse hosts. EMBO Report 2003; 4: 932—936.

Lemaitre B. The road to Toll. Nat Rev Immunol 2004; 4: 521—527.

Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5—11.

Carneiro LA , Travassos LH , Philpott DJ Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect 2004; 6: 609—616.

Akira S. , Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499—511.

Lien E. , Golenbock DT Adjuvants and their signaling pathways: beyond TLRs. Nat Immunol 2003; 4: 1162—1164.

Hayashi F. Smith KD , Ozinsky et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 . Nature 2001; 410: 1099—1103.

Hemmi H. , Takeuchi O. , Kawai T. et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740—745.

10.

Zhang D. , Zhang MS , Hayden MS et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522—1526.

11.

Underhill DM Toll-like receptors: networking for success . Eur J Immunol 2003; 33: 1767—1775.

12.

Ozinsky A. , Underhill JD , Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766—13771.

13.

Morr M. , Takeuchi O. , Akira S. , Simon MM , Muhlradt PF et al. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur J Immunol 2002; 32: 3337—3347.

14.

Takeuchi O. , Sato S. , Horiuchi T. et al. Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169: 10—14.

15.

Travassos LH , Girardin SE , Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Report 2004; 5: 1000—1006.

16.

Kaisho T. , Akira S. Pleiotropic function of Toll-like receptors. Microbes Infect 2004; 6: 1388—1394.

17.

Edelson BT , Unanue ER MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol 2002; 169: 3869—3875.

18.

Haziot A. , Hijiya N. , Gangloff SC , Silver J. , Goyert SM Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. J Immunol 2001; 166: 1075—1078.

19.

Latz E. et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190-198.

20.

Hornef MW , Normark BH , Vandewalle A. , Normark S. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003 ; 198: 1225—1235.

21.

Cossart P. , Sansonetti PJ Bacterial invasion: the paradigms of entero-invasive pathogens. Science 2004; 304: 242—248.

22.

Hornef MW , Wick MJ , Rhen M. , Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses . Nat Immunol 2002; 3: 1033—1040.

23.

Girardin SE , Tournebize R. , Mavris M. et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Report 2001; 2: 736—742.

24.

Ting JP , Davis BK CATERPILLER: a novel gene family important in immunity, cell death, and diseases . Annu Rev Immunol 2005; 23: 387—414.

25.

Girardin SE , Travassos LH , Herve M. et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003.

26.

Girardin SE , Philpott DJ The role of peptidoglycan recognition in innate immunity. Eur J Immunol 2004; 34: 1777—1782.

27.

Boneca IG The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 2005; 8: 46—53.

28.

Girardin SE , Boneca IG , Carneiro LA et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300: 1584—1587.

29.

Chamaillard M. , Hashimoto, Horie Y et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid . Nat Immunol 2003; 4: 702—707.

30.

Hugot JP , Chamaillard M. , Zouali H. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599—603.

31.

Ogura Y. , Bonen DK , Inohara N. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603—606.

32.

Bouma G. , Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521—533.

33.

Chamaillard M. , Philpott D. , Girardin SE et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100: 3455—3460.

34.

Ogura Y. , Saab L. , Chen FF et al. Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease small star, filled. Genomics 2003; 81: 369—377.

35.

Kobayashi KS , Chamaillard M. , Ogura Y. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731—734.

36.

Maeda S. , Hsu LC , Liu H. et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734—738.

37.

Ayabe T. , Ashida T. , Kohgo Y. , Kono T. The role of Paneth cells and their antimicrobial peptides in innate host defense . Trends Microbiol 2004; 12: 394—398.

38.

Li J. , Moran T. , Swanson E. et al. Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004.

39.

Netea MG , Kullberg BJ , De Jong DJ et al. NOD2 mediates antiinflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 2004; 34: 2052—2059.

40.

Adam A. , Petit JF , Lrfrancier P. , Lederer E. Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol Cell Biochem 1981; 41: 27—47.

41.

Takada H. , Yokoyama S. , Yang S. Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 2002; 8: 337—342.

42.

Chen CM et al. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways . J Biol Chem 2004; 279: 25876—25882.

43.

Traub S. , Kubasch N. , Morath S. et al. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J Biol Chem 2004; 279: 8694—8700.

44.

Fritz JH , Girardin SE , Fitting C. et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2- activating agonists. Eur J Immunol 2005; 35: 2459—2470.

45.

Watanabe T. , Kitani A. , Murray PJ , Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800—808